Average Co-Inventor Count = 3.20
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Gilead Sciences, Inc. (24 from 919 patents)
2. Gilead Pharmasset LLC (9 from 79 patents)
3. Gilead Calistoga LLC (3 from 16 patents)
4. Sierra Oncology, Inc. (2 from 4 patents)
5. Glaxosmithkline LLC (1 from 356 patents)
39 patents:
1. 12486252 - Solid forms of a Cot inhibitor compound
2. RE50497 - (N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
3. 12202849 - Crystalline forms of tenofovir alafenamide
4. 11845739 - Solid forms of an HIV capsid inhibitor
5. 11833143 - Choline salt forms of an HIV capsid inhibitor
6. 11655237 - Solid forms of a Cot inhibitor compound
7. 11613553 - Methods of preparing 1'-cyano nucleosides
8. RE49445 - N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
9. 11440928 - Crystalline forms of tenofovir alafenamide
10. 11266638 - Choline salt forms of an HIV capsid inhibitor
11. 11267799 - Solid forms of an HIV capsid inhibitor
12. 11203599 - Solid forms of an antiviral compound
13. 11117886 - Methods and intermediates for preparing therapeutic compounds
14. 10849892 - Choline salt forms of an HIV capsid inhibitor
15. 10851125 - Crystalline forms of ethyl ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl)(phenoxy)phosphoryl(-L-alaninate